Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Details Narrative)

v3.21.2
Common Stock (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
May 11, 2021
Jun. 18, 2020
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2021
May 04, 2021
Common stock, shares authorized     22,800,000   22,800,000 22,800,000 40,000,000
Common stock outstanding     12,982,500   12,000,000 12,982,500  
IPO [Member]              
Public offering shares 3,000,000            
Offering price $ 7.00            
Subsequent Event [Member] | IPO [Member]              
Public offering shares 3,000,000            
Offering price $ 7.00            
Proceeds from public offering $ 21,000,000            
Series A Preferred Stock [Member]              
Public offering shares   2,047,500     6,896,406    
Offering price         $ 1.685    
2020 Stock Plan [Member]              
Common stock reserved shares     1,650,000     1,650,000  
Public offering shares     604,404        
2020 Stock Plan [Member] | Series A Preferred Stock [Member]              
Stock conversion of shares           2,047,500  
2020 Stock Plan [Member] | Series A Preferred Stock [Member] | Future Milestone Warrants [Member]              
Stock conversion of shares           6,896,406  
Restricted Stock [Member] | CEO [Member]              
Number of shares of restricted common stock       982,500      
Restricted stock grant date fair value       $ 0.1083      
Related Party Investor [Member]              
Common stock outstanding     12,000,000     12,000,000  
Due from related party         $ 3,500    
Maximum [Member]              
Common stock, shares authorized     22,800,000     22,800,000